FSP Welcomes New President, Marilyn Bui, MD, PhD

The FSP is pleased to announce the new FSP President, Marilyn Bui, MD, PhD. Dr. Bui was officially sworn in as the next FSP President during the FSP Annual Business Meeting on February 18, 2023 at the FSP Annual Pathology Conference in Orlando. Dr. Bui will serve as President for the 2023-2025 term.

Dr. Bui is a Senior Member in the Department of Pathology at Moffitt Cancer Center & Research Institute. She serves as the Scientific Director of the Analytic Microscopy Core. She is also a Professor and the Director of the Cytopathology Fellowship at the University of South Florida (USF) Morsani College of Medicine. She is a patient-centered pathologist who combines research, education, advocacy, and service for better patient care and received the 2019 College of American Pathologists (CAP) Distinguished Patient Care Award. Dr. Bui is the study Pathologist for multiple research grants. She has published over 210 peer-reviewed articles, 30 book chapters and 3 books. She is an inventor and has received 3 patents in Digital Pathology and cancer diagnostics. Dr. Bui is an award-winning educator and mentor. She has frequently (>200) lectured both nationally and internationally, including keynote presentations. She is the editorial board member of multiple journals.  Dr. Bui values the service to professional societies and views it as an important mechanism to influence policies and standards to help improve the quality of patient care in a broader sense. She serves on committees organizing national meetings on Pathology education. Her leadership experience includes but is not limited to being the President of the Digital Pathology Association (2019), the President of the Medical Staff of Moffitt Cancer Center (2018-2020), the President of Chinese American Pathologists Association (2021-2022), the President-elect of Florida Society of Pathologists (2021-2023), Chair of the Publications Committee and the Editorial Board of CAP Today (2018-2021), and the Chair  of the expert panel of HER2 quantitative image analysis of breast cancer guidelines of CAP (2016-2019). She is the current Chair of the Digital and Computational Pathology committee and the Vice Speaker of the House of Delegates of the CAP. Dr. Bui is passionate about advocating the critical role of Pathology and Laboratory Medicine in precision medicine. She has been interviewed and featured in journals/magazines, podcasts, and a documentary film (see HER2Know.com).